A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene
Clinical trial NCT02506517 · COMPLETED
Trial details
- NCT number
- NCT02506517
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2023-05-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.